Elevated Soluble Podoplanin Associates with Hypercoagulability in Patients with Nephrotic Syndrome

被引:5
|
作者
Ji, Ying [1 ]
Wang, Yan-Li [2 ]
Xu, Fang [1 ]
Jia, Xi-Bei [1 ]
Mu, Su-Hong [1 ]
Lyu, Hui-Yan [1 ]
Yuan, Xue-Ying [1 ]
Na, Shi-Ping [1 ]
Bao, Yu-Shi [1 ]
机构
[1] Harbin Med Univ, Affiliated Hosp 1, Dept Nephrol, 23 Youzheng St, Harbin 150001, Peoples R China
[2] Harbin Med Univ, Affiliated Hosp 1, Dept Rheumatol, Harbin, Peoples R China
关键词
podoplanin; C-type lectin-like receptor 2; nephrotic syndrome; hypercoagulable state; thrombosis; VENOUS THROMBOSIS; TUMOR-METASTASIS; RECEPTOR CLEC-2; THROMBOEMBOLISM; PLATELETS; INTEGRITY; ROLES; MICE;
D O I
10.1177/10760296221108967
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Podoplanin (PDPN) promotes platelet aggregation and activation by interacting with C-type lectin-like receptor 2(CLEC-2) on platelets. The interaction between the upregulated PDPN and platelet CLEC-2 stimulates venous thrombosis. PDPN was identified as a risk factor for coagulation and thrombosis in inflammatory processes. Hypercoagulability is defined as the tendency to develop thrombosis according to fibrinogen and/or D dimer levels. Nephrotic syndrome is also considered to be a hypercoagulable state. The aim of this study is to investigate the association of soluble PDPN/CLEC-2 with hypercoagulability in nephrotic syndrome. Thirty-five patients with nephrotic syndrome and twenty-seven healthy volunteers were enrolled. PDPN, CLEC-2 and GPVI concentrations were tested by enzyme-linked immunosorbent assay (ELISA). Patients with nephrotic syndrome showed higher serum levels of PDPN and GPVI in comparison to healthy controls (P < .001, P = .001). PDPN levels in patients with nephrotic syndrome were significantly correlated with GPVI (r = 0.311; P = .025), hypoalbuminemia (r = -0.735; P < .001), hypercholesterolemia (r = 0.665; P < .001), hypertriglyceridemia (r = 0.618; P < .001), fibrinogen (r = 0.606; P < .001) and D-dimer (r = 0.524; P < .001). Area under the curve (AUC) for the prediction of hypercoagulability in nephrotic syndrome using PDPN was 0.886 (95% CI 0.804-0.967, P < .001). Cut-off value for the risk probability was 5.88 ng/ml. The sensitivity of PDPN in predicting hypercoagulability was 0.806, and the specificity was 0.846. When serum PDPN was >5.88 ng/ml, the risk of hypercoagulability was significantly increased in nephrotic syndrome (OR = 22.79, 95% CI 5.92-87.69, P < .001). In conclusion, soluble PDPN levels were correlated with hypercoagulability in nephrotic syndrome. PDPN has the better predictive value of hypercoagulability in nephrotic syndrome as well as was a reliable indicator of hypercoagulable state.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Hypercoagulability risk factors associated with venous thromboembolic events in patients with idiopathic membranous nephropathy and nephrotic syndrome: a prospective observational study
    Ismail, Gener
    Harza, Mihai
    Tuta, Liliana
    Jurubita, Roxana
    Motoi, Otilia
    Ditoiu, Alecse Valerian
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2013, 21 (2-4): : 135 - 143
  • [32] NEPHROTIC SYNDROME IN ELDERLY PATIENTS
    SHISHKIN, AN
    SHULUTKO, BI
    KOMOVA, OP
    GALLARAGA, HA
    VRACHEBNOE DELO, 1989, (11): : 79 - 81
  • [33] DYSPROTEINEMIA IN PATIENTS WITH A NEPHROTIC SYNDROME
    ADO, MA
    KLINICHESKAYA MEDITSINA, 1983, 61 (10): : 38 - 43
  • [34] NEPHROTIC SYNDROME IN ELDERLY PATIENTS
    Ben ayed, Tasnim
    Gorsane, Imen
    Trabelsi, Raja
    Ounissi, Mondher
    Ben Abdallah, Taieb
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 774 - 774
  • [35] Management of patients with nephrotic syndrome
    de Seigneux, Sophie
    Martin, Pierre-Yves
    SWISS MEDICAL WEEKLY, 2009, 139 (29-30) : 416 - 422
  • [36] LIPIDURIA IN PATIENTS WITH NEPHROTIC SYNDROME
    NEVEROV, NI
    NIKITINA, EA
    TERAPEVTICHESKII ARKHIV, 1992, 64 (06) : 16 - 18
  • [37] NEPHROTIC CRISIS - AN URGENT CONDITION IN PATIENTS WITH NEPHROTIC SYNDROME
    Kozlovskaya, L. V.
    Bobkova, I. N.
    Chebotareva, N. V.
    Fomin, V. V.
    Roschupkina, S. V.
    TERAPEVTICHESKII ARKHIV, 2012, 84 (06) : 68 - 73
  • [38] Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma
    Xia, Yu
    Liu, Li
    Xiong, Ying
    Bai, Qi
    Wang, Jiajun
    Xi, Wei
    Qu, Yang
    Xu, Jiejie
    Guo, Jianming
    CANCER SCIENCE, 2016, 107 (09) : 1243 - 1249
  • [39] Elevated serum CA-125 levels in patients with nephrotic syndrome-induced ascites
    Sevinc, A
    Buyukberber, S
    Sari, R
    Turk, HM
    Ates, M
    ANTICANCER RESEARCH, 2000, 20 (2B) : 1201 - 1203
  • [40] Elevated urinary vascular endothelial growth factor in nephrotic syndrome
    Shalaby, S.
    Mohamed, H.
    Safar, R.
    Taha, S.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1639 - 1639